BEYOND AIR XAIR 深 沪
等待开盘 08-15 09:30:00 美东时间
2.32
-0.130
-5.31%
华盛通- 最 高2.40
- 今 开2.40
- 成交量 22.98万股
- 最 低 2.2901
- 昨 收 2.45
- 总市值 1076.41万
- 52周最高 13.522
- 市盈率 静 --
- 换手率 4.95%
- 52周最低 2.225
- 委 比 59.68%
- 总股本 463.97万
- 历史最高 328.20
- 量 比 0.62
- 振 幅 4.49%
- 历史最低 2.2901
- 每 手 1
- 风险率 0.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅95.33%！HC Wainwright & Co.上调Insmed目标价至240美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Insmed"买入"评级，目标价从120美元升至240美元；巴克莱：维持Transocean"超配"评级，目标价从3.5美元升至4美元
08-14 09:25
D. Boral Capital Maintains Buy on Beyond Air, Maintains $11 Price Target
D. Boral Capital analyst Jason Kolbert maintains Beyond Air (NASDAQ:XAIR) with a Buy and maintains $11 price target.
08-14 00:11
Beyond Air shares are trading lower after the company reported worse-than-expected Q1 EPS results.
Beyond Air shares are trading lower after the company reported worse-than-expec...
08-13 20:26
Beyond Air Affirms FY2026 Sales Guidance of $12.00M-$16.00M vs $13.32M Est
Beyond Air (NASDAQ:XAIR) affirms FY2026 sales outlook from $12.00 million-$16.00 million to $12.00 million-$16.00 million vs $13.32 million estimate.
08-13 04:09
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
A Preview Of Beyond Air's Earnings
Beyond Air (NASDAQ:XAIR) is gearing up to announce its quarterly earnings on Tu...
08-12 01:03
Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast
Beyond Air Inc., a medical device and biopharmaceutical company focused on nitric oxide (NO) therapies, announced it will release its Q1 2025 financial results on August 12, 2025, followed by a conference call and webcast at 4:30 PM ET. Beyond Air is dedicated to improving patient lives through NO treatments for respiratory illnesses, neurological disorders, and solid tumors. Its LungFit® PH system has received FDA approval and CE Mark for treati...
07-25 12:00
Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.
Beyond Air, Inc. has secured a national group purchasing agreement with Premier, Inc., allowing U.S. hospitals and healthcare providers to access special pricing for its LungFit PH system and disposable NO₂ Smart Filters. The agreement facilitates the transition from traditional cylinder-based NO systems to Beyond Air's innovative, cylinder-free solution. The LungFit PH system generates nitric oxide on-demand from ambient air using Ionizer™ techn...
07-22 11:30
D. Boral Capital Initiates Coverage On Beyond Air with Buy Rating, Announces Price Target of $11
D. Boral Capital analyst Jason Kolbert initiates coverage on Beyond Air (NASDAQ:XAIR) with a Buy rating and announces Price Target of $11.
07-17 20:52
